Details of the Drug Reposition

General Information of This Drug (ID: DMMC45B)

Drug Name
Teriparatide   DMMC45B
Synonyms Forteo; Forteo (TN); Teriparatide (genetical recombination); Teriparatide (USAN/INN); Teriparatide (genetical recombination) (JAN)
Therapeutic Class
Bone Density Conservation Agents
Drug Type
Peptide
Structure
3D MOL is unavailable 2D MOL

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
4 Approved Indication(s)
Indication Name Indication ID ICD-11 Status REF
Exostosis DIS3VKEI N.A. Approved [1]
Myelofibrosis DISIMP21 2A20.2 Approved [1]
Osteoporosis DISF2JE0 FB83.0 Approved [1]
Osteogenesis imperfecta DIS7XQSD LD24.K0 Approved [2]
------------------------------------------------------------------------------------
1 Discontinued in Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Psoriatic disorder DISKD4Y8 EA90 Discontinued in Phase 2 [3]
------------------------------------------------------------------------------------
1 Investigative Indication(s)
Indication Name Indication ID ICD-11 Status REF
Autosomal dominant hypocalcemia DISW4TUE 5A50.0Y Investigative [1]
------------------------------------------------------------------------------------

References

1 Teriparatide FDA Label
2 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4448).
3 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800030730)